Valueinvesting, as Anjo-Roch pointed out with RMAT involved it's an entirely different ball game,my belief is MSB will be the first company to have multi RMATs ..Currently they are one in 15 companies to achieve rmat status and most others have only one application .
RMAT is designed to save lives .and provides an accelerated pathway to achieve that as quick as possible ..The FDA designed it and are very keen for success ,I'm sure there is much dialogue going with MSB currently ..My view only ....cheers
- Forums
- ASX - By Stock
- TEMCELL
MSB
mesoblast limited
Add to My Watchlist
12.3%
!
$2.43
Valueinvesting, as Anjo-Roch pointed out with RMAT involved it's...
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
